glp-1 colorectal cancer death risk study november 2025 GLP‐1 receptor agonists and the for cancer: A meta‐analysis of randomized controlled trials Association between GLP-1 receptor agonists

But she said there are more issues to address

Obesity, diabetes, and associated comorbidities have emerged as a modern health crisis and a priority area of concern for health insurers

2020;4(4):bvz042

As of 2024, three GLP1 agonists have been approved for weight loss

The mechanism of action (MOA) of GLP-1 drugs involves mimicking the natural hormone glucagon-like peptide-1, which has several beneficial effects in managing blood glucose and supporting weight loss

In contrast, control mice with matching weight loss were not protected from atherosclerosis, suggesting that liraglutide has anti-atherogenic effects independent of weight loss